Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in clinical trials for bronchial asthma.

T Nakagawa1

  • 1Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan. tnakagaw@marianna-u.ac.jp

Methods and Findings in Experimental and Clinical Pharmacology
|June 17, 2003
PubMed
Summary

New therapies for bronchial asthma target allergic inflammation, offering alternatives to inhaled corticosteroids (ICS) with potentially improved safety profiles. Research explores agents like phosphodiesterase 4 inhibitors and cytokine modulators.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acholeplasma laidlawii has tRNA genes in the 16S-23S spacer of the rRNA operon.

Journal of bacteriology·1992
Same author

[Clinical significance of IgG4 antibody determination in children against egg white, milk, soybean and Dermatophagoides farinae].

Arerugi = [Allergy]·1992
Same author

The monocytic cell line SKM-1 strongly expresses the myeloperoxidase gene.

Leukemia·1992
Same author

Aldosterone responses to angiotensin II in anorexia nervosa.

Acta psychiatrica Scandinavica·1992
Same author

Origin of macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in amniotic fluid.

Asia-Oceania journal of obstetrics and gynaecology·1992
Same author

Mathematical assessment of the spatial distribution of Langerhans cells in guinea pig epidermis.

Journal of dermatological science·1992

Area of Science:

  • Pulmonology
  • Immunology
  • Pharmacology

Background:

  • Bronchial asthma is a chronic airway inflammatory disease.
  • Inhaled corticosteroids (ICS) are primary anti-inflammatory treatments but have potential side effects.
  • This necessitates exploring adjunctive, alternative, and novel therapeutic strategies.

Purpose of the Study:

  • To review emerging anti-inflammatory therapies for bronchial asthma.
  • To highlight agents targeting specific components of allergic inflammation.
  • To discuss treatments with potentially better safety profiles than ICS.

Main Methods:

  • Literature review of current and developing asthma therapies.
  • Focus on novel anti-inflammatory mechanisms.
  • Analysis of therapeutic agents targeting allergic inflammation pathways.

Related Experiment Videos

Main Results:

  • Several new therapeutic classes are under development for asthma.
  • These include phosphodiesterase 4 inhibitors, cytokine modulators, chemokine receptor antagonists, and antisense oligonucleotides.
  • These agents aim to inhibit key inflammatory mediators with potentially improved safety.

Conclusions:

  • Novel therapeutic agents offer promising alternatives for asthma management.
  • Targeting specific inflammatory pathways may provide safer and more effective asthma control.
  • Further research is needed to establish the efficacy and safety of these new therapies.